+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Nutrigenomics Market Size, Share & Trends Analysis Report By Product (Reagents & Kits, and Services), By End User (Hospitals & Clinics, Online Platforms, and Others), By Application, By Country and Growth Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 106 Pages
  • February 2024
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5943446
The Europe Nutrigenomics Market would witness market growth of 16.4% CAGR during the forecast period (2023-2030).

The market is witnessing an expansion of nutrigenomic testing services offered by various companies. Beyond basic genetic testing kits, specialized services focused on comprehensive nutrigenomic analysis are becoming more prevalent. These services delve deeper into the genetic factors influencing nutrition, providing consumers with a more thorough understanding of their personalized dietary needs. Another notable trend is the integration of gut microbiome analysis into nutrigenomics.

The intricate relationship between the gut microbiota and nutrient metabolism is gaining attention, with companies offering combined genetic and microbiome testing services. This dual approach aims to provide a more holistic understanding of how genetic and microbial factors contribute to individualized nutrition. Moreover, Collaboration between Nutritional genomicsand the food industry is increasing as companies seek to align their product offerings with personalized nutrition trends. This collaboration involves the development of genetically informed food products and supplements designed to cater to specific genetic profiles. Such partnerships aim to create a synergy between the science of Nutritional genomics and the practical implementation of personalized dietary solutions.

There is an increasing number of CVD cases in the United Kingdom. It can help identify genetic factors that may predispose individuals to certain cardiovascular conditions. In accordance with the data from the International Diabetes Federation (IDF), diabetes prevalence (9.2%) and the number of individuals with diabetes (61 million) are expected to increase by 13% in the European region by 2045, according to IDF projections. The region exhibits the highest incidence of type 1 diabetes annually, with 31,000 new cases and the greatest number of children and adolescents affected (295,000). Additionally, at USD 3,086, the region has the second-highest average cost per person with diabetes. Diabetes incurred 189.3 billion USD in expenditures in 2021, representing 19.6% of global expenditures. Hence, rising CVD and diabetes cases in Europe will drive the growth of the regional market.

The Germany market dominated the Europe Nutrigenomics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $104.8 Million by 2030. The UK market is exhibiting a CAGR of 15.4% during (2023 - 2030). Additionally, The France market would experience a CAGR of 17.2% during (2023 - 2030).

Based on Product, the market is segmented into Reagents & Kits, and Services. Based on End User, the market is segmented into Hospitals & Clinics, Online Platforms, and Others. Based on Application, the market is segmented into Obesity, Diabetes, Cardiovascular Diseases, and Cancer Research. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

  • Genova Diagnostics
  • Metagenics, Inc.
  • Nutrigenomix Inc.
  • Unilever PLC
  • The Gene Box
  • Cura Integrative Medicine
  • Fagron Genomics S.L.U. (GX Sciences Inc.)
  • Xcode Life Sciences Private Limited
  • DNA Life
  • BASF SE

Market Report Segmentation

By Product
  • Reagents & Kits
  • Services
By End User
  • Hospitals & Clinics
  • Online Platforms
  • Others
By Application
  • Obesity
  • Diabetes
  • Cardiovascular Diseases
  • Cancer Research
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Nutrigenomics Market, by Product
1.4.2 Europe Nutrigenomics Market, by End User
1.4.3 Europe Nutrigenomics Market, by Application
1.4.4 Europe Nutrigenomics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Europe Nutrigenomics Market by Product
4.1 Europe Reagents & Kits Market by Country
4.2 Europe Services Market by Country
Chapter 5. Europe Nutrigenomics Market by End User
5.1 Europe Hospitals & Clinics Market by Country
5.2 Europe Online Platforms Market by Country
5.3 Europe Others Market by Country
Chapter 6. Europe Nutrigenomics Market by Application
6.1 Europe Obesity Market by Country
6.2 Europe Diabetes Market by Country
6.3 Europe Cardiovascular Diseases Market by Country
6.4 Europe Cancer Research Market by Country
Chapter 7. Europe Nutrigenomics Market by Country
7.1 Germany Nutrigenomics Market
7.1.1 Germany Nutrigenomics Market by Product
7.1.2 Germany Nutrigenomics Market by End User
7.1.3 Germany Nutrigenomics Market by Application
7.2 UK Nutrigenomics Market
7.2.1 UK Nutrigenomics Market by Product
7.2.2 UK Nutrigenomics Market by End User
7.2.3 UK Nutrigenomics Market by Application
7.3 France Nutrigenomics Market
7.3.1 France Nutrigenomics Market by Product
7.3.2 France Nutrigenomics Market by End User
7.3.3 France Nutrigenomics Market by Application
7.4 Russia Nutrigenomics Market
7.4.1 Russia Nutrigenomics Market by Product
7.4.2 Russia Nutrigenomics Market by End User
7.4.3 Russia Nutrigenomics Market by Application
7.5 Spain Nutrigenomics Market
7.5.1 Spain Nutrigenomics Market by Product
7.5.2 Spain Nutrigenomics Market by End User
7.5.3 Spain Nutrigenomics Market by Application
7.6 Italy Nutrigenomics Market
7.6.1 Italy Nutrigenomics Market by Product
7.6.2 Italy Nutrigenomics Market by End User
7.6.3 Italy Nutrigenomics Market by Application
7.7 Rest of Europe Nutrigenomics Market
7.7.1 Rest of Europe Nutrigenomics Market by Product
7.7.2 Rest of Europe Nutrigenomics Market by End User
7.7.3 Rest of Europe Nutrigenomics Market by Application
Chapter 8. Company Profiles
8.1 Genova Diagnostics
8.1.1 Company Overview
8.1.2 SWOT Analysis
8.2 Metagenics, Inc.
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Acquisition and Mergers:
8.2.3 SWOT Analysis
8.3 Nutrigenomix Inc.
8.3.1 Company Overview
8.3.2 Recent strategies and developments:
8.3.2.1 Partnerships, Collaborations, and Agreements:
8.3.2.2 Product Launches and Product Expansions:
8.3.3 SWOT Analysis
8.4 Unilever PLC
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 SWOT Analysis
8.5 The Gene Box
8.5.1 Company Overview
8.5.2 SWOT Analysis
8.6 Cura Integrative Medicine
8.6.1 Company Overview
8.6.2 SWOT Analysis
8.7 Fagron Genomics S.L.U. (GX Sciences Inc.)
8.7.1 Company Overview
8.7.2 SWOT Analysis
8.8 Xcode Life Sciences Private Limited
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Product Launches and Product Expansions:
8.8.3 SWOT Analysis
8.9 DNA Life
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. BASF SE
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expense
8.10.5 SWOT Analysis

Companies Mentioned

  • Genova Diagnostics
  • Metagenics, Inc.
  • Nutrigenomix Inc.
  • Unilever PLC
  • The Gene Box
  • Cura Integrative Medicine
  • Fagron Genomics S.L.U. (GX Sciences Inc.)
  • Xcode Life Sciences Private Limited
  • DNA Life
  • BASF SE

Methodology

Loading
LOADING...